Type 2 diabetes is no longer a lifelong sentence; emerging research shows it can be reversed With strategic lifestyle changes ...

This new definition, published January 14 in the journal The Lancet Diabetes & Endocrinology, could shift the paradigm of clinical care for the 890 million adults worldwide who are currently ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

The observational study referenced earlier - which showed a high intake of lycopene reduced the risk of prostate cancer by 21 ...

An endocrinologist and a dietitian weigh in on why you can’t lose weight in menopause and how eating more calories and ...

Aharon, Ph.D., Co-Founder & CEO of AEYE Health, in conversation with Jake Laznik, Senior Breaking News Desk Manager, The ...

Once you have had a heart attack or have been diagnosed with a heart problem - there is always confusion about whether you ...

Image: Adobe Stock Polsky and colleagues determined CGM use frequency, neonatal ICU admission rates and mean gestation from the Triple C study, a retrospective study comparing health outcomes for ...

Having a 'moon face' can be a sign of Cushing syndrome, but that's typically not the only symptom. Here's what experts want ...

Not only is alcohol a risk to your liver, but it can also significantly increase your risk for multiple types of cancer, a ...